FolioLanternBeta
ADPTAdaptive Biotechnologies Corp

Julie Rubinstein

President and COO at Adaptive Biotechnologies Corp, as of Oct 13, 2026Sold $16.3M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
378K
shares held after the latest filing, Adaptive Biotechnologies Corp
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1.06M
shares sold, past 12 months
48
days with sales
$1.9M
largest single day, Mar 11, 2026
1
company filed for

Share of stake sold at Adaptive Biotechnologies Corp is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $8.2M under a disclosed plan$8.2MMarApr 2026: $5.2M under a disclosed planAprMayJunJulAugSepOct 2026: $2.9M under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Adaptive Biotechnologies Corp (ADPT)President and COOJun 26, 2019Oct 13, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.